Comorbidity | No. (%) of patients with the condition who died | No. (%) patients without the condition who died | OR (95% CI) |
---|---|---|---|
Age | 1.05 (1.03–1.06) | ||
Male sex | 81 (1.2) | 49 (1.6) | 0.75 (0.52–1.07) |
STEMI and NSTEMI | 97 (3.1) | 33 (0.5) | 6.71 (4.51–9.98) |
Hemorrhagic and ischemic stroke, TIA | 5 (19.2) | 125 (1.2) | 19.02 (7.06–51.25) |
Atrial fibrillation | 45 (3.4) | 85 (1.0) | 3.65 (2.53–5.27) |
Atrioventricular block | 14 (6.2) | 116 (1.2) | 5.58 (3.15–9.87) |
Cardiac arrest, VT/VF, cardiogenic shock | 76 (17.9) | 54 (0.6) | 39.06 (27.12–56.26) |
Acute pulmonary embolism | < 5 | 127 (1.3) | 13.11 (3.82–45.07) |
Acute respiratory failure | 13 (36.1) | 117 (1.2) | 48.23 (23.85–97.52) |
Acute kidney failure | 31 (20.8) | 99 (1.0) | 26.24 (16.86–40.84) |
Pulmonary hypertension | 12 (5.2) | 118 (1.2) | 4.52 (2.46–8.32) |
Implantable cardioverter-defibrillator | < 5 | 127 (1.3) | 2.39 (0.75–7.64) |
Heart failure | 23 (7.9) | 107 (1.1) | 7.84 (4.92–12.50) |
PAD and CVD | 29 (2.2) | 101 (1.1) | 1.95 (1.29–2.97) |
Chronic pulmonary disease | 18 (1.9) | 112 (1.2) | 1.53 (0.93–2.53) |
Liver disease | 9 (10.8) | 121 (1.2) | 9.98 (4.89–20.40) |
Diabetes mellitus | 37 (1.5) | 93 (1.2) | 1.21 (0.82–1.77) |
Hypertension | 67 (1.2) | 63 (1.4) | 0.87 (0.61–1.23) |
Chronic kidney disease | 27 (2.8) | 103 (1.1) | 2.56 (1.67–3.93) |
Cancer | 7 (7.3) | 123 (1.2) | 6.34 (2.88–13.97) |
Neurological disorders | 27 (20.9) | 103 (1.0) | 25.46 (15.97–40.59) |
Coagulopathy | 7 (8.2) | 123 (1.2) | 7.25 (3.28–16.02) |
Obesity | 22 (0.9) | 108 (1.4) | 0.66 (0.42–1.05) |
Fluid and electrolyte disorders | < 5 | 126 (1.2) | 14.41 (4.90–42.43) |
Note: CI = confidence interval, CVD = cerebrovascular disease, NSTEMI = non–ST-elevation myocardial infarction, OR = odds ratio, PAD = peripheral arterial disease, STEMI = ST-elevation myocardial infarction, TIA = transient ischemic attack, VT/VF = ventricular tachycardia/ventricular fibrillation.